Table 2.
Immunohistochemical results for PON
| MC | PAC | FC | PDCa | UCa | AG | FA | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PON | S | CY | S | CY | S | CY | S | CY | S | CY | S | CY | S | CY |
| (++) | 38% | 0% | 54% | 0% | 0% | 0% | 0% | 0% | 100% | 0% | 0% | 0% | 0% | 0% |
| (+) | 31% | 0% | 24% | 0% | 0% | 0% | 0% | 0% | 0% | 100% | 0% | 0% | 0% | 0% |
| (F+) | 15% | 0% | 15% | 0% | 28% | 0% | 100% | 50% | 0% | 0% | 10% | 0% | 17% | 0% |
| (−) | 15% | 100% | 7% | 100% | 72% | 100% | 0% | 50% | 0% | 0% | 90% | 100% | 83% | 100% |
| fc | 38% | N.A. | 27% | N.A. | 72% | N.A. | N.A. | N.A. | N.A. | N.A. | (20%) | N.A. | 89% | N.A. |
*PON Periostin, MIC Microcarcinoma, PAC Papillary thyroidal carcinoma, FC Follicular carcinoma, PDCa Poorly differentiated carcinoma, UCa Undifferentiated carcinoma, AG Adenomatous goiter, FA Follicular adenoma
*S Stroma, CY Cytoplasm, fc Fibrous capsule, (−) Negative [0%], (F+) Focally positive [1–9%], (+) Positive [10–49%], (++) Diffusely positive [≥50%], L.I. Labeling index, N.A. Not available